Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients
José Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, et al.
Clinical Infectious Diseases (2014) Vol. 58, Iss. 11, pp. 1549-1553
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 125
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
Charles Béguelin, Darius Moradpour, Roland Sahli, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 2, pp. 297-303
Open Access | Times Cited: 121
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Alexander Stockdale, Mas Chaponda, Apostolos Beloukas, et al.
The Lancet Global Health (2017) Vol. 5, Iss. 10, pp. e992-e1003
Open Access | Times Cited: 120
Optimal management of hepatitis B virus infection – EASL Special Conference
Pietro Lampertico, Mala K. Maini, George Papatheodoridis
Journal of Hepatology (2015) Vol. 63, Iss. 5, pp. 1238-1253
Closed Access | Times Cited: 102
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydìn, Zaigham Abbas, Marı́a Buti, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 5, pp. 1008-1015
Open Access | Times Cited: 100
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydìn, Onur Keskın, Çağdaş Kalkan, et al.
The Journal of Infectious Diseases (2018) Vol. 217, Iss. 8, pp. 1184-1192
Open Access | Times Cited: 83
Hepatitis B, hepatitis C, and mortality among HIV-positive individuals
Alicia Thornton, Sophie José, Sanjay Bhagani, et al.
AIDS (2017) Vol. 31, Iss. 18, pp. 2525-2532
Open Access | Times Cited: 77
Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV‐positive patients
José Vicente Fernández-Montero, Pablo Barreiro, Carmen de Mendoza, et al.
Journal of Viral Hepatitis (2015) Vol. 23, Iss. 1, pp. 47-52
Closed Access | Times Cited: 67
Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection
Gema M. Lledó, Itzíar Carrasco, Laura Benítez‐Gutiérrez, et al.
AIDS (2018) Vol. 32, Iss. 16, pp. 2347-2352
Closed Access | Times Cited: 63
Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies
Habiba Kamal, Romina Fornes, Johanna Simin, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 10, pp. 1431-1442
Open Access | Times Cited: 42
Hepatitis B Virus and Hepatitis Delta Virus
Chloe L. Thio, Claudia Hawkins
Elsevier eBooks (2015), pp. 1815-1839.e7
Closed Access | Times Cited: 54
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long‐term tenofovir or entecavir
Giuseppina Brancaccio, M. Fasano, Adriano Grossi, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 8, pp. 1071-1076
Closed Access | Times Cited: 43
Advances in hepatitis B therapeutics
Vincent Soriano, Pablo Barreiro, Edward R. Cachay, et al.
Therapeutic Advances in Infectious Disease (2020) Vol. 7
Open Access | Times Cited: 40
Hepatitis delta infection among persons living with HIV in Europe
Charles Béguelin, Andrew Atkinson, Anders Boyd, et al.
Liver International (2023) Vol. 43, Iss. 4, pp. 819-828
Open Access | Times Cited: 13
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Cheng‐Jian Xu, Kerstin Port, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 7, pp. 597-606
Open Access | Times Cited: 13
Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
Aslıhan Demirel, Süleyman Uraz, Zeynep Deniz, et al.
Journal of Viral Hepatitis (2023) Vol. 31, Iss. 2, pp. 120-128
Closed Access | Times Cited: 13
Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy
Yu‐Shan Huang, Hsin‐Yun Sun, Shu‐Yuan Ho, et al.
Clinical Infectious Diseases (2025)
Open Access
Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients
Verdiana Zulian, Leonidas Salichos, Chiara Taibi, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 280-280
Open Access
Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain
Carlos Ordieres, C.A. Navascués, M.L. González-Diéguez, et al.
European Journal of Gastroenterology & Hepatology (2016) Vol. 29, Iss. 3, pp. 277-283
Closed Access | Times Cited: 41
New treatment options for delta virus: Is a cure in sight?
Cihan Yurdaydìn
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 6, pp. 618-626
Closed Access | Times Cited: 35
Hepatitis delta and HIV infection
Vincent Soriano, Kenneth E. Sherman, Pablo Barreiro
AIDS (2017) Vol. 31, Iss. 7, pp. 875-884
Closed Access | Times Cited: 38
Human immunodeficiency virus and liver disease: A comprehensive update
Kenneth E. Sherman, Marion G. Peters, David L. Thomas
Hepatology Communications (2017) Vol. 1, Iss. 10, pp. 987-1001
Open Access | Times Cited: 37
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen
Florian A. Lempp, Stephan Urban
Viruses (2017) Vol. 9, Iss. 7, pp. 172-172
Open Access | Times Cited: 35
Alcohol use, viral hepatitis and liver fibrosis among HIV‐positive persons in West Africa: a cross‐sectional study
Antoine Jaquet, Gilles Wandeler, Marcellin Nouaman, et al.
Journal of the International AIDS Society (2017) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection
Nicole Ferrante, Vincent Lo Re
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 4, pp. 405-414
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top